OVIT (OncoVista Innovative Therapies) Interest Expense: $-0.03 Mil (TTM As of Sep. 2015)


What is OncoVista Innovative Therapies Interest Expense?

OncoVista Innovative Therapies OVIT Interest Expense is $-0.03 Mil as of Sep. 2015.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. OncoVista Innovative Therapies's interest expense for the three months ended in Sep. 2015 was $ -0.01 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2015 was $-0.03 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. OncoVista Innovative Therapies's Operating Income for the three months ended in Sep. 2015 was $ -0.32 Mil. OncoVista Innovative Therapies's Interest Expense for the three months ended in Sep. 2015 was $ -0.01 Mil. OncoVista Innovative Therapies did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

OncoVista Innovative Therapies  (OTCPK:OVIT) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

OncoVista Innovative Therapies's Interest Expense for the three months ended in Sep. 2015 was $-0.01 Mil. Its Operating Income for the three months ended in Sep. 2015 was $-0.32 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2015 was $0.00 Mil.

OncoVista Innovative Therapies's Interest Coverage for the quarter that ended in Sep. 2015 is calculated as

OncoVista Innovative Therapies did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

OncoVista Innovative Therapies Interest Expense Historical Data

* Premium members only.

The historical data trend for OncoVista Innovative Therapies's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoVista Innovative Therapies Interest Expense Chart

OncoVista Innovative Therapies Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.15 -0.02 -0.01 0.00 -0.01

OncoVista Innovative Therapies Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 -0.00 -0.01 -0.01 -0.01

OncoVista Innovative Therapies Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-0.03 Mil mean?
OncoVista Innovative Therapies (OVIT) has a Interest Expense of $-0.03 Mil as of Sep. 2015. Interest Expense is the amount a company pays on its long-term debt. View historical data on OncoVista Innovative Therapies and its competitors.
Is OncoVista Innovative Therapies' Interest Expense too high?
OncoVista Innovative Therapies' current Interest Expense is $-0.03 Mil.
How does OncoVista Innovative Therapies' Interest Expense compare to RSPI and HSTC?
OncoVista Innovative Therapies' Interest Expense of $-0.03 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on OncoVista Innovative Therapies and its competitors. OncoVista Innovative Therapies's current Interest Expense is $-0.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoVista Innovative Therapies stock overvalued right now?
OncoVista Innovative Therapies (OVIT) has a current Interest Expense of $-0.03 Mil. The current Interest Expense is $-0.03 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For OncoVista Innovative Therapies (OVIT), the current Interest Expense is $-0.03 Mil as of Sep. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoVista Innovative Therapies Business Description

Address 14785 Omicron Drive, Suite 104, San Antonio, TX, USA, 78245
OncoVista Innovative Therapies Inc is a biopharmaceutical company. It is engaged in developing anticancer therapies by utilizing tumor-associated biomarkers.